1
|
Multicolor colorimetric assay for copper ion detection based on the etching of gold nanorods. Mikrochim Acta 2022; 189:420. [PMID: 36251083 DOI: 10.1007/s00604-022-05515-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2022] [Accepted: 09/28/2022] [Indexed: 10/24/2022]
Abstract
An effective, selective, and multicolor colorimetric assay for Cu2+ detection based on the regulation of peroxidase-like nanozyme-mediated etching of gold nanorods (Au NRs) is proposed. Cu2+-creatinine complex is selected as the nanozyme that exhibits excellent peroxidase-like activity even in the case of low concentration of Cu2+, which can catalyze 3,3,5,5-tetramethylbenzidine (TMB) to produce oxidized TMB (TMB+) in the presence of hydrogen peroxide, and TMB+ is oxidized to generate TMB2+ after adding H+, and the TMB2+ can etch Au NRs. The determination of Cu2+ is achieved based on the blue shift of the longitudinal localized surface plasmon resonance peak of Au NRs. Under the optimal conditions, the developed colorimetric assay exhibits high sensitivity for the detection of Cu2+ (limit of detection is 0.034 μM) with a wide linear range of 0.05-4.0 μM (R2 = 0.987). The solution shows a rainbow-like color in response to the increase of Cu2+ concentration, which can realize the semi-quantitative detection of Cu2+ by naked eyes. In addition, the developed method exhibits excellent selectivity for Cu2+-detection. The established method was used for the determination of Cu2+ in lake water, soil, and normal human serum with satisfactory recovery of spiked samples.
Collapse
|
2
|
Li K, Xu X, Liu W, Yang S, Huang L, Tang S, Zhang Z, Wang Y, Chen F, Qian K. A Copper-Based Biosensor for Dual-Mode Glucose Detection. Front Chem 2022; 10:861353. [PMID: 35444996 PMCID: PMC9014126 DOI: 10.3389/fchem.2022.861353] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 03/15/2022] [Indexed: 12/02/2022] Open
Abstract
Glucose is a source of energy for daily activities of the human body and is regarded as a clinical biomarker, due to the abnormal glucose level in the blood leading to many endocrine metabolic diseases. Thus, it is indispensable to develop simple, accurate, and sensitive methods for glucose detection. However, the current methods mainly depend on natural enzymes, which are unstable, hard to prepare, and expensive, limiting the extensive applications in clinics. Herein, we propose a dual-mode Cu2O nanoparticles (NPs) based biosensor for glucose analysis based on colorimetric assay and laser desorption/ionization mass spectrometry (LDI MS). Cu2O NPs exhibited excellent peroxidase-like activity and served as a matrix for LDI MS analysis, achieving visual and accurate quantitative analysis of glucose in serum. Our proposed method possesses promising application values in clinical disease diagnostics and monitoring.
Collapse
Affiliation(s)
- Kai Li
- Department of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin, China
| | - Xiaoyu Xu
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Wanshan Liu
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Shouzhi Yang
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Lin Huang
- Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Shuai Tang
- Department of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin, China
| | - Ziyue Zhang
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Yuning Wang
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
- *Correspondence: Yuning Wang, ; Fangmin Chen, ; Kun Qian,
| | - Fangmin Chen
- Department of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin, China
- *Correspondence: Yuning Wang, ; Fangmin Chen, ; Kun Qian,
| | - Kun Qian
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China
- Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
- *Correspondence: Yuning Wang, ; Fangmin Chen, ; Kun Qian,
| |
Collapse
|